Lician Pro · $19.99/mo or $149/yr · AAPL vs MSFT
Impact BioMedical, Inc. (IBO) SEC filings
Impact BioMedical, Inc. (IBO) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Latest reported IBO revenue for 2025-12-31 was $32.0K. Net income was -$11.8M. Revenue was down 36.0% from 2022-12-31 to 2025-12-31. IBO currently screens at market cap $7.6M. The IBO filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Impact BioMedical, Inc. said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
Earnings & events
All eventsEvent insights for IBO — what management said, what changed, and why it matters.
Recent filings
IBO SEC filings FAQ
What is the latest IBO SEC filing?
The latest cached Impact BioMedical, Inc. (IBO) filing on this page is 8-K · Oct 9, 2026. Filings: https://lician.com/sec/ibo
What is the latest IBO filing accession number?
The latest cached Impact BioMedical, Inc. (IBO) accession number on this page is 0001493152-26-046572. Filing: https://lician.com/sec/ibo/0001493152-26-046572
Which item codes are on the latest IBO filing?
Cached item codes on the latest Impact BioMedical, Inc. (IBO) 8-K are 5.03, 9.01.
How many IBO SEC filings are listed on this page?
This page lists 3 cached Impact BioMedical, Inc. (IBO) SEC filings. Filings: https://lician.com/sec/ibo
What events are listed on the IBO SEC page?
Cached event headlines on this Impact BioMedical, Inc. (IBO) SEC page: "IBO earnings". Events: https://lician.com/sec/ibo
What are IBO's latest revenue and net income?
Latest cached Impact BioMedical, Inc. (IBO) revenue for Dec 31, 2025 was $32.0K. Net income was -$11.8M. Statements: https://lician.com/financials/ibo